Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/irv.12375 http://scihub22266oqcxt.onion/10.1111/irv.12375 26859306!4814860!26859306     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Influenza+Other+Respir+Viruses 2016 ; 10 (3): 205-10 Nephropedia Template TP {{tp|p=26859306|t=2016. Clinical outcomes in outpatient respiratory syncytial virus infection in immunocompromised children |pdf=|usr=}}{{26859306}} gab.com Text Clinical outcomes in outpatient respiratory syncytial virus infection in immunocompromised children JO: Influenza Other Respir Viruses http://www.kidney.de/pget.php?&tw=1&pmid=26859306 #FOAvip BACKGROUND: Immunocompromised patients are at high risk for morbidity and mortality due to respiratory syncytial virus (RSV) infection. Increasingly, pediatric patients with malignancy or undergoing transplantation are managed primarily as outpatients. Data regarding the clinical presentation and outcomes of RSV in the outpatient pediatric immunocompromised population are limited. METHODS: We performed a retrospective cohort study of children with hematologic malignancy or hematopoietic or solid organ transplant with laboratory-confirmed RSV infection diagnosed as outpatients at an academic medical center between 2008 and 2013. RESULTS: Of 54 patients with RSV detected while outpatients, 15 (28%) were hospitalized, 7 (13%) received ribavirin, and one (2%) received intravenous immunoglobulin. One (2%) patient was critically ill, but there were no deaths due to RSV infection. Fever (P < 0.01) was associated with increased risk of hospitalization. CONCLUSIONS: Most immunocompromised children with RSV detected while outpatients did not require hospitalization or receive antiviral treatment. Potential studies of RSV therapies should consider inclusion of patients in an ambulatory setting. Twit Text FOAVip Clinical outcomes in outpatient respiratory syncytial virus infection in immunocompromised children ????Influenza Other Respir Viruses http://www.kidney.de/pget.php?&tw=1&pmid=26859306 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26859306 #FOAvip English Wikipedia <ref>{{Cite pmid|26859306}}</ref> Clinical outcomes in outpatient respiratory syncytial virus infection in immunocompromised children #MMPMID26859306 Chu HY; Chin J; Pollard J; Zerr DM; Englund JA Influenza Other Respir Viruses 2016[May]; 10 (3): 205-10 PMID26859306show ga BACKGROUND: Immunocompromised patients are at high risk for morbidity and mortality due to respiratory syncytial virus (RSV) infection. Increasingly, pediatric patients with malignancy or undergoing transplantation are managed primarily as outpatients. Data regarding the clinical presentation and outcomes of RSV in the outpatient pediatric immunocompromised population are limited. METHODS: We performed a retrospective cohort study of children with hematologic malignancy or hematopoietic or solid organ transplant with laboratory-confirmed RSV infection diagnosed as outpatients at an academic medical center between 2008 and 2013. RESULTS: Of 54 patients with RSV detected while outpatients, 15 (28%) were hospitalized, 7 (13%) received ribavirin, and one (2%) received intravenous immunoglobulin. One (2%) patient was critically ill, but there were no deaths due to RSV infection. Fever (P < 0.01) was associated with increased risk of hospitalization. CONCLUSIONS: Most immunocompromised children with RSV detected while outpatients did not require hospitalization or receive antiviral treatment. Potential studies of RSV therapies should consider inclusion of patients in an ambulatory setting. |*Immunocompromised Host[MESH] |Adolescent[MESH] |Antiviral Agents/therapeutic use[MESH] |Child[MESH] |Child, Preschool[MESH] |Cohort Studies[MESH] |Female[MESH] |Hematologic Neoplasms/complications/epidemiology/virology[MESH] |Humans[MESH] |Immunoglobulins, Intravenous/therapeutic use[MESH] |Infant[MESH] |Infant, Newborn[MESH] |Male[MESH] |Outpatients[MESH] |Respiratory Syncytial Virus Infections/complications/drug therapy/*therapy/virology[MESH] |Respiratory Syncytial Viruses/isolation & purification[MESH] |Retrospective Studies[MESH] |Ribavirin/therapeutic use[MESH] |Risk Factors[MESH] |Transplantation[MESH] |Treatment Outcome[MESH] |United States[MESH]Clinical outcomes in outpatient respiratory syncytial virus infection (epmc).pdf DeepDyve Pubget Overpricing